Fierce Healthcare
DECEMBER 8, 2021
Amazon launches new elder care subscription service Alexa Together with emergency assistance, fall detection. rtorrence. Wed, 12/08/2021 - 11:21.
pharmaphorum
DECEMBER 8, 2021
Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less effective against the new COVID-19 variant Omicron. A study by the African Health Research Institute (AHRI) has found that the less of immune protection was “extensive but incomplete,” meaning that some level of immunity was retained against the vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
DECEMBER 8, 2021
SAMSHA offers $30M in grants to boost harm reduction strategies to curb opioid abuse. rking. Wed, 12/08/2021 - 13:33.
pharmaphorum
DECEMBER 8, 2021
Personal relationships have been the dominant force in sales for generations but the pandemic has ripped up this conveyer belt of convenience. More than 60% of clinicians are happy to either connect solely via technology or via a hybrid arrangement and there is no going back. The pharmaceutical industry became stuck in a groove of letting doctor-rep relationships obscure the challenge of delivering complex information in perfectly pitched presentations.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
DECEMBER 8, 2021
AHA, Johns Hopkins, Athenahealth, others launch campaign to make telehealth permanent. agliadkovskaya. Wed, 12/08/2021 - 15:55.
pharmaphorum
DECEMBER 8, 2021
French digital health startup HypnoVR has completed a first-round financing, raising €4.5 million ($5.1 million) that will be used to roll out its virtual reality-based hypnosis therapies. The company has developed a an individually tailored immersive VR platform that it uses to deliver clinical hypnosis techniques to alleviate chronic pain, anxiety and discomfort during medical procedures like surgery.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 8, 2021
China’s Shanghai Henlius Biotech says its experimental PD-1 inhibitor serplulimab has extended survival when added to chemotherapy in a phase 3 trial as first-line therapy for extensive stage small cell lung cancer (ES-SCLC), setting up regulatory filings. The trial compared serplulimab (formerly HLX10) plus carboplatin and etoposide chemotherapy in previously untreated patients with ES-SCLC , and showed a higher overall survival than chemo alone, according to the company.
Fierce Healthcare
DECEMBER 8, 2021
States with strong antitrust laws challenge more hospital mergers but still fall short on addressing consolidation. dmuoio. Wed, 12/08/2021 - 12:18.
pharmaphorum
DECEMBER 8, 2021
Acadia Pharma’s trofinetide has hit its efficacy targets in a phase 3 trial involving girls with the devastating neurological disorder Rett syndrome, although safety has dampened enthusiasm a little. Top-line data from the LAVENDER study in 187 girls and young women with Rett have shown that trofinetide had a significant effect on two primary efficacy measures at 12 weeks – raising the hope that it may become the first-ever approved therapy for the disorder.
Fierce Healthcare
DECEMBER 8, 2021
Urban Institute: Nearly 13M had problems affording prescriptions before COVID-19 pandemic. rking. Wed, 12/08/2021 - 16:31.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
DECEMBER 8, 2021
AstraZeneca and Daiichi Sankyo have reported new data with their antibody-drug conjugate for triple-negative breast cancer (TNBC), as they build a case to challenge Gilead’s already-marketed Trodelvy. New data from the TROPION-PanTumor01 study of datopotamab deruxtecan (Dato-DXd) showed a 34% objective response rate (ORR) with AZ and Daiichi’s drug when used as a therapy for people with metastatic TNBC that had relapsed after earlier treatment.
Fierce Healthcare
DECEMBER 8, 2021
Bright Health banks $750M investment from Cigna Ventures, New Enterprise Associates. pminemyer. Wed, 12/08/2021 - 14:44.
pharmaphorum
DECEMBER 8, 2021
pharmaphorum’s founder, Dr Paul Tunnah, talks with Debiopharm Innovation Fund’s CEO Tanja Dowe at Frontiers Health as part of his mini series of interviews from Frontiers Health. . Live from the conference in Milan, Tanja discusses how Debiopharm Innovation Fund concentrates on series A and series B investments, and recently released a report outlining what’s next for start-ups who’ve received series A funding.
Fierce Healthcare
DECEMBER 8, 2021
SoftBank leads mental health startup Cerebral's $300M round, propelling valuation to $4.8B. hlandi. Wed, 12/08/2021 - 13:10.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
DECEMBER 8, 2021
Sited in Pennsylvania, the excipients specialistâs new facility reportedly will work toward advancing drug delivery research and boosting speed to market.
Roots Analysis
DECEMBER 8, 2021
Biopreservation is the exclusive biological approach designated for the preservation of cells, tissues and organs ex-vivo for the purpose of storage, shipment and transportation. Biopreservation media is one of the most crucial entity in conferring effectiveness. The selection of the type of media depends upon the considerable time duration desired for the storage, type of biological material to be preserved and the purpose of biopreservation.
Fierce Healthcare
DECEMBER 8, 2021
Jury: UnitedHealth must pay TeamHealth $60M in damages in Nevada case. pminemyer. Wed, 12/08/2021 - 11:38.
Med Ed 101
DECEMBER 8, 2021
I encounter patients on a daily basis who are taking medications for urinary issues. Incontinence, frequency, BPH, and frequent UTIs are common problems in geriatrics that can lead to the use of medications. Here are some of my pet peeves with these issues. No One Ever Reassesses OAB Medications Patients who get placed on medications […]. The post Pet Peeves With Urinary Issues appeared first on Med Ed 101.
Fierce Healthcare
DECEMBER 8, 2021
3 Healthcare Marketing Tips for 2022. admin. Wed, 12/08/2021 - 13:21.
Pharma Times
DECEMBER 8, 2021
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
Pharma Times
DECEMBER 8, 2021
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
Expert insights. Personalized for you.
131 
Let's personalize your content